These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Use of parenteral anticoagulants in patients with coronary syndrome]. Costabel JP; Duronto E; Guetta J; Ceresetto J; Guardiani F; Fescina JP; Procopio G; Casey M; Higa C; Villareal R; Bonorino J; Lamelas P Medicina (B Aires); 2023; 83(6):948-965. PubMed ID: 38117714 [TBL] [Abstract][Full Text] [Related]
7. Fondaparinux: A cornerstone drug in acute coronary syndromes. Khan MY; Ponde CK; Kumar V; Gaurav K World J Cardiol; 2022 Jan; 14(1):40-53. PubMed ID: 35126871 [TBL] [Abstract][Full Text] [Related]
8. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice. Zhang Y; Zhang Y; Liu Z; Zhang B; Liu G; Chen K Biomed Pharmacother; 2020 Oct; 130():110758. PubMed ID: 34321166 [TBL] [Abstract][Full Text] [Related]
9. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143 [TBL] [Abstract][Full Text] [Related]
11. 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Coons JC; Battistone S Ann Pharmacother; 2008 Jul; 42(7):989-1001. PubMed ID: 18577763 [TBL] [Abstract][Full Text] [Related]
12. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. Stone GW; Mehran R; Goldstein P; Witzenbichler B; Van't Hof A; Guagliumi G; Hamm CW; Généreux P; Clemmensen P; Pocock SJ; Gersh BJ; Bernstein D; Deliargyris EN; Steg PG J Am Coll Cardiol; 2015 Jan; 65(1):27-38. PubMed ID: 25572507 [TBL] [Abstract][Full Text] [Related]
14. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study]. Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427 [No Abstract] [Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
16. Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study. Yu XF; Chen HW; Xu J; Xu QZ; Zhang XH; Li BB; Xu BL; Ma LK Front Cardiovasc Med; 2022; 9():932054. PubMed ID: 36386368 [TBL] [Abstract][Full Text] [Related]
17. Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Barbato E; Mehilli J; Sibbing D; Siontis GCM; Collet JP; Thiele H; Eur Heart J; 2021 Apr; 42(14):1368-1378. PubMed ID: 32860046 [No Abstract] [Full Text] [Related]
18. Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Huang X; Chen S; Redfors B; Zhang Y; Souza CF; Mehran R; Bansilal S; Kirtane AJ; Brener SJ; Feite F; Dangas GD; Ben-Yehuda O; Stone GW Coron Artery Dis; 2020 Jan; 31(1):59-65. PubMed ID: 31809479 [TBL] [Abstract][Full Text] [Related]
19. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Cavender MA; Sabatine MS Lancet; 2014 Aug; 384(9943):599-606. PubMed ID: 25131979 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes. Maxwell CB; Holdford DA; Crouch MA; Patel DA Ann Pharmacother; 2009 Apr; 43(4):586-95. PubMed ID: 19336655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]